Market Movers: Illumina's Divestment and Stock Surges

U.S. stock futures edge higher as investors anticipate potential Federal Reserve interest rate cuts next year. Gene-sequencing group Illumina plans to divest blood cancer-test seller Grail to appease antitrust regulators. Shares in China's SenseTime slip after the death of its founder. Gold prices rise due to the Fed's dovish outlook. Oil prices are volatile as traders consider Russian export reductions, attacks on commercial vessels, weak business morale data from Germany, and a forecast from Goldman Sachs.